Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients. [electronic resource]
Producer: 20180104Description: 449-456 p. digitalISSN:- 1791-7530
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- adverse effects
- Carcinoma, Renal Cell -- drug therapy
- Czech Republic
- Databases, Factual
- Disease-Free Survival
- Female
- Humans
- Indazoles
- Indoles -- therapeutic use
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Nephrectomy
- Proto-Oncogene Proteins c-kit -- antagonists & inhibitors
- Pyrimidines -- adverse effects
- Pyrroles -- therapeutic use
- Receptors, Platelet-Derived Growth Factor -- antagonists & inhibitors
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Registries
- Retrospective Studies
- Sulfonamides -- adverse effects
- Sunitinib
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.